Abstract
Pancreatic cancer has an extremely poor prognosis mainly due to lack of effective treatment options. Radiotherapy is mostly applied to locally advanced cases, although tumor radioresistance limits the effectiveness. Profilin1, a novel tumor suppressor gene, was reported to be down-regulated in various cancers and associated with tumor progression. The objective of this study was to demonstrate how profilin1 affected pancreatic cancer radiosensitivity. We showed profilin1 was down-regulated in pancreatic cancer cells after exposure to radiation, and re-expression of profilin1 suppressed tumor cell viability and increased DNA damage following irradiation. Further studies revealed that up-regulation of profilin1 facilitated apoptosis and repressed autophagy induced by irradiation, which might sensitize pancreatic cancer cells to radiation treatment. Our findings may provide a novel therapeutic strategy for sensitizing pancreatic cancer to radiotherapy.
Keywords: Apoptosis, autophagy, DNA damage, pancreatic cancer, profilin1, radiation.
Current Molecular Medicine
Title:Profilin1 Sensitizes Pancreatic Cancer Cells to Irradiation by Inducing Apoptosis and Reducing Autophagy
Volume: 13 Issue: 8
Author(s): H. Cheng, J. Li, C. Liu, W. Yao, Y. Xu, T. S. Frank, X. Cai, S. Shi, Y. Lu, Y. Qin, L. Liu, J. Xu, J. Long, Q.-X. Ni, M. Li and X.-J. Yu
Affiliation:
Keywords: Apoptosis, autophagy, DNA damage, pancreatic cancer, profilin1, radiation.
Abstract: Pancreatic cancer has an extremely poor prognosis mainly due to lack of effective treatment options. Radiotherapy is mostly applied to locally advanced cases, although tumor radioresistance limits the effectiveness. Profilin1, a novel tumor suppressor gene, was reported to be down-regulated in various cancers and associated with tumor progression. The objective of this study was to demonstrate how profilin1 affected pancreatic cancer radiosensitivity. We showed profilin1 was down-regulated in pancreatic cancer cells after exposure to radiation, and re-expression of profilin1 suppressed tumor cell viability and increased DNA damage following irradiation. Further studies revealed that up-regulation of profilin1 facilitated apoptosis and repressed autophagy induced by irradiation, which might sensitize pancreatic cancer cells to radiation treatment. Our findings may provide a novel therapeutic strategy for sensitizing pancreatic cancer to radiotherapy.
Export Options
About this article
Cite this article as:
Cheng H., Li J., Liu C., Yao W., Xu Y., Frank S. T., Cai X., Shi S., Lu Y., Qin Y., Liu L., Xu J., Long J., Ni Q.-X., Li M. and Yu X.-J., Profilin1 Sensitizes Pancreatic Cancer Cells to Irradiation by Inducing Apoptosis and Reducing Autophagy, Current Molecular Medicine 2013; 13 (8) . https://dx.doi.org/10.2174/15665240113139990060
DOI https://dx.doi.org/10.2174/15665240113139990060 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Novel Applications of Recombinant Lactic Acid Bacteria in Therapy and in Metabolic Engineering
Recent Patents on Biotechnology Probiotic Research in Australia, New Zealand and the Asia-Pacific Region
Current Pharmaceutical Design Uptake of [¹⁸F]tetrafluoroborate in MCF-7 Breast Cancer Cells is Induced after Stimulation of the Sodium Iodide Symporter
Current Cancer Drug Targets Repurposed Drugs in Metabolic Disorders
Current Topics in Medicinal Chemistry RNA Interference (RNAi) Patents and Human Health Related Applications of RNAi
Recent Patents on DNA & Gene Sequences ANTI-ADHESION Evolves To a Promising Therapeutic Concept in Oncology
Current Medicinal Chemistry Molecular Docking Studies of the Antitumoral Activity and Characterization of New Chalcone
Current Topics in Medicinal Chemistry Soy Protein Remnants Digested by Gastro-duodenal Proteases can Alter Microbial Interactions and Intestinal Cholesterol Absorption
Current Proteomics Mining of Network Markers for Brain Tumor from Transcriptome and Interactome Data
Current Bioinformatics Recent Research Trends on Bismuth Compounds in Cancer Chemoand Radiotherapy
Current Medicinal Chemistry Current State of Development of Genome Analysis in Livestock
Current Genomics Regulatory T Cells: Major Players in the Tumor Microenvironment
Current Pharmaceutical Design Main Isoflavones Found in Dietary Sources as Natural Anti-inflammatory Agents
Current Drug Targets Ontologies of Drug Discovery and Design for Neurology, Cardiology and Oncology
Current Pharmaceutical Design Development of Vasculature Targeting Strategies for the Treatment of Chronic Inflammatory Diseases
Current Drug Targets - Inflammation & Allergy Epigenetic Mechanism Involved in the HBV/HCV-Related Hepatocellular Carcinoma Tumorigenesis
Current Pharmaceutical Design Editorial [Hybrid Imaging (Guest Editors: Birger Hesse and Abass Alavi)]
Current Medical Imaging Medicinal Chemistry Perspective of Fused Isoxazole Derivatives
Current Topics in Medicinal Chemistry MicroRNAs: Regulators of TLR2-Mediated Probiotic Immune Responses
MicroRNA Cyclophilin A as a Target of Cisplatin Chemosensitizers
Current Cancer Drug Targets